Related Experiment Video
Updated: Jul 5, 2026
08:00
Spatiotemporal Control of Protein Activity through Optogenetic Allosteric Regulation
Published on: October 4, 2024
Atypical regulation of SRC-3.
Michael J Garabedian1, Susan K Logan
1Department of Microbiology, and the New York University (NYU) Cancer Institute, NYU School of Medicine, 550 First Avenue, New York, NY 10016, USA. michael.garabedian@nyumc.org
Trends in Biochemical Sciences
|May 27, 2008
Summary
Overexpression of steroid receptor coactivator 3 (SRC-3) promotes breast cancer. A new study reveals atypical protein kinase C (aPKC) phosphorylation protects SRC-3 from degradation, linking it to estrogen-driven cell growth.
Area of Science:
- Molecular Biology
- Oncology
- Biochemistry
Background:
- Steroid receptor coactivator 3 (SRC-3) overexpression is linked to increased breast cancer incidence.
- Understanding the regulation of SRC-3 is crucial for developing targeted breast cancer therapies.
Purpose of the Study:
- To elucidate the mechanism protecting SRC-3 from proteasomal degradation.
- To investigate the role of atypical protein kinase C (aPKC) and estrogen receptor alpha (ERalpha) in SRC-3 regulation.
Main Methods:
- The study likely involved biochemical assays to assess protein stability and phosphorylation.
- Investigated the interaction between SRC-3, aPKC, and ERalpha.
Main Results:
- SRC-3 is protected from proteasomal degradation through aPKC-mediated phosphorylation.
- This phosphorylation occurs in an ERalpha-dependent manner.
- This mechanism couples increased SRC-3 levels with enhanced estrogen-dependent cellular proliferation.
Conclusions:
- A novel regulatory pathway for SRC-3 stability has been identified.
- This pathway involves aPKC-mediated phosphorylation and ERalpha signaling.
- The findings offer new insights into estrogen-driven breast cancer development.
Related Concept Videos
01:15Receptor Downregulation in MVBs
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
01:22PI3K/mTOR/AKT Signaling Pathway
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a rapamycin-insensitive companion...
01:00Enzyme-linked Receptors
Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
01:26Receptor Tyrosine Kinases
Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
01:09GPCRs Regulate Adenylyl Cylase Activity
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...
Two...